propofol in critically ill patients, and subsequently determining the best strategy for administering propofol. Methods: Costs of propofol-related infection and the different strategies of administration of propofol were computed according to the literature and microcosting method. The additional length of stay in ICU due to major infections related to propofol administration was estimated using the disability model, assuming a cost of CHF 2'118/intensive care unit day (local cost). The cost of each strategy was estimated based on all costs and on the probability of major infections related to propofol administration. Results: According to the links found in the literature by genotyping bacteria (syringe-patient), we assumed that a patient has a mean 22.6% risk of developing an infection by a contaminated preparation of propofol. Thus, the ready-to-use syringe and syringes drawn from vials have an infection probability of 0.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.